Skip to main

National Health (Pharmaceutical Benefits) Legislation Amendment (Commonwealth Price—Mark-ups) Determination 2020 (PB 134 of 2020)

No longer in force
Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
F2020L0171324 December 2020 - 11 May 2021

Details

Title ID
F2020L01713
Registered
24 December 2020
Effective
24 December 2020 - 11 May 2021
Series
PB 134 of 2020
Type
Amending

Any available explanatory material for this instrument can be found on the Downloads tab

Date repealed
12 May 2021
Repealed by

Disallowance and tabling

All legislative instruments that are registered must be presented for scrutiny in each House of the Parliament and, unless an exemption applies, they may be disallowed by either House. When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.

This title is subject to disallowance under:

House of Representatives

  • Legislative Instrument
    02 February 2021
  • Explanatory Statement
    02 February 2021

Senate

  • Legislative Instrument
    02 February 2021
  • Explanatory Statement
    02 February 2021